Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Oswaldo L. Castro, MD
Researcher Professor Emeritus of Medicine and Pediatrics
Howard University College of Medicine
1840 7th Street, NW
Washington, DC, United States
Dr. Oswaldo Castro is Professor Emeritus of Medicine at the Howard University College of Medicine in Washington, DC, and also a consultant to the Sickle Cell Clinic at the National Institutes of Health in Bethesda, MD, United States of America. He received his medical school training at Albert-Ludwigs University in Freiburg, Germany, and his hematology specialty training at Yale University, New Haven, CT. Dr. Castro is certified in internal medicine and in hematology by the American Board of Internal Medicine. He joined the Howard University faculty in 1974 as Deputy Director of the Center for Sickle Cell Disease. From 1990 to 2006, he was the Center’s Director. He now serves as a special advisor to the Center. Dr. Castro has had a life-long interest in the clinical and research aspects of sickle cell disease and has published over 100 scientific articles dealing primarily with complications of this disorder.
Interests: Pulmonary hypertension, transfusion medicine and iron deficiency as they relate to sickle cell disease.
Representative Publications:
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease
Related Content
-
Mary Hulihan, DrPHDr. Mary Hulihan is the Health Scientist...
-
Nadia Ewing, MDNadia Ewing, M.D., is a clinical profess...
-
Four Solutions for Sickle Cell Disease SupportWhen Precious Lee was a year old, she be...
-
IU Nurse Invents Medical Device for People With Sickle Cell Diseasehttps://www.youtube.com/watch?v=TjE3Urth...
-
Winthrop-University HospitalNYU Winthrop's pediatric hematologists p...
-
Columbia University Medical CenterThe Division of Pediatric Hematology at ...
-
Podcast: How New Gene Therapies for SCD May Impact Women’s FertilityAs we closed 2023, the Food and Drug Ad...